Interestingly, while Th2 cytokines typically oppose IFN‐γ’s effects, our findings suggest a more complex interaction where M2 macrophages in the tumour microenvironment may exhibit hybrid phenotypes, co‐expressing both M2 markers (but CD206 negative/low) and IFN‐γ response genes. The gene discussed is MRC1; the disease is neoplasm.